IP Library Granted Patent US 7,553,646
Granted Patent B2
US 7,553,646 · App. 11/460,532 · Granted Jun 30, 2009

Microbial sulfoxidation and amidation of benzhdrylsulfanyl carboxylic acids and uses thereof

Assignee: University of Iowa Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,646
App. No.
11/460,532
Granted
Jun 30, 2009
Kind
B2
Abstract

The present invention provides novel methods for the synthesis of racemic and enantiomers of modafinil via microbial oxidation-amidation transformation. The methods include the successive oxidation-amidation of benzhydrylsulfanyl carboxylic acid to produce racemic and enantiomers of modafinil using at least one microorganism of yeast, bacteria, or fungus. Also disclosed are pharmaceutical compositions of racemic and enantiomers of modafinil along with their use in the treatment of diseases, including attention deficit hyperactivity disorder and drug addiction.

Claims (26)

1. A method of preparing an (S)-enantiomer of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) comprising:

(a) subjecting benzhydrylsulfanyl carboxylic acid to an oxidation reaction using a microorganism to obtain an (S)-sulfoxide product of (S)-benzhydrylsulfinyl carboxylic acid; and

(b) subjecting the (S)-sulfoxide product to an amidation reaction using a microorganism to obtain an (S)-sulfoxide-amide product of (+)-(S)-modafinil.

2. The method of claim 1 wherein the same microorganism is used in the oxidation and amidation reactions.

3. The method of claim 1 wherein the microorganism used for the oxidation reaction is a bacteria, yeast, or fungus.

4. The method of claim 1 wherein the microorganism used for the amidation reaction is a bacteria, yeast, or fungus.

5. The method of claim 3 wherein the bacteria used for the oxidation reaction is genetically engineered to express at least one oxygenase.

6. The method of claim 5 wherein the oxygenase is selected from the group consisting of dioxygenase, napthalene dioxygenase, toluene dioxygenase, chloroperoxidase, monooxygenase, cyclopentanone monooxygenase, cyclohexanone monooxygenase.

7. The method of claim 3 wherein the microorganism used for the oxidation reaction is selected from the group consisting of Beauveria bassiana, Microsporum gypseum, Mortierella isabellina, Caldariomycesfumago, Mortierella elongata, Helminthosporium sp, Amycolaptosis orientalis, Thamnidium elegans.

8. The method of claim 4 wherein the bacteria used for the amidation reaction is Bacillus subtilis or Amycolaptosis orientalis.

9. A method of preparing an (+)-(S)-enantiomer of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) comprising:

(a) subjecting benzhydrylsulfanyl carboxylic acid to an oxidation reaction using Beauveria bassiana to obtain (S)-benzhydiylsulfinyl carboxylic acid; and

(b) subjecting the (S)-benzhydrylsulfinyl carboxylic acid to an amidation reaction using Bacillus subtilis to obtain (+)-(S)-modafinil.

10. A method of preparing (−)-(R)-enantiomer of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) comprising:

(a) subjecting benzhydrylsulfanyl carboxylic acid to an oxidation reaction using a microorganism to obtain an (R)-sulfoxide product of (R)-benzhydrylsulfinyl carboxylic acid; and

(b) subjecting the (R)-sulfoxide product to an amidation reaction using a microorganism to obtain an (R)-sulfoxide-amide product of (−)-(R)-modafinil.

11. The method of claim 10 wherein the same microorganism is used in the oxidation and amidation reactions.

12. The method of claim 10 wherein the microorganism used for the oxidation reaction is a bacteria, yeast, or fungus.

13. The method of claim 10 wherein the microorganism used for the amidation reaction is a bacteria, yeast, or fungus.

14. The method of claim 12 where the microorganism is selected from the group consisting of Rhodococcus rhodochrous or Sphingomonas sp. and Cylindrocarpon radicicola.

15. The method of claim 12 wherein the bacteria used for the oxidation reaction is genetically engineered to comprises at least one oxygenase.

16. The method of claim 15 wherein the oxygenase is a dioxygenase, napthalene dioxygenase, toluene dioxygenase, monooxygenase, alkane monooxygenase, cyclohexanone monooxygenase.

17. The method of claim 13 wherein the bacteria used for the amidation reaction is Bacillus subtilis or Amycolaptosis orientalis.

18. A method of preparing an (−)-(R)-enantiomer of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) comprising:

(a) subjecting benzhydrylsulfanyl carboxylic acid to an oxidation reaction using Sphingomonas sp to obtain (R)-benzhydrylsulfinyl carboxylic acid; and

(b) subjecting the (R)-benzhydrylsulfinyl carboxylic acid to an amidation reaction using the bacteria genetically engineered comprising toluene dioxygenase to obtain (−)-(R)-modafinil.

Assignments (5)
CONFIRMATORY LICENSE Recorded Dec 30, 2009
From: UNIVERSITY OF IOWA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 023716/0795 →
CONFIRMATORY LICENSE Recorded Jun 27, 2007
From: UNIVERSITY OF IOWA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 019485/0574 →
CONFIRMATORY LICENSE Recorded Apr 12, 2007
From: UNIVERSITY OF IOWA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 019153/0467 →
CONFIRMATORY LICENSE Recorded Sep 7, 2006
From: UNIVERSITY OF IOWA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 018229/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2006
From: OLIVO, HORACIO F.; OSORIO-LOZADA, ANTONIO VICTOR
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION
Reel/Frame 018040/0426 →
Continuity (2)
Provisional Application 6070332200 · Jul 28, 2005
Related Publication 20070026507A1 · Feb 1, 2007